Interleaved TMS-fMRI in Ultra-treatment Resistant Depression
Condition(s) studied
Investigational drug(s) / intervention(s)
rTMS: Accelerated iTBS treatment
Study summary
This is a study that will recruit patients from the neurosurgery clinic and the regular TMS clinic. It's a smaller study designed to collect brain imaging pre-treatment and then use image guided TMS to treat patient with a one week "accelerated" rTMS protocol using the research TMS machine that is housed in Dr. Sean Nestor's lab. The idea is to examine whether severe treatment resistant depression has a different brain signature than less severe/TRD and whether the investigators can get a therapeutic response from patients that would otherwise undergo neurosurgery or will ultimately undergo neurosurgery.
Eligibility
Primary outcome measure(s)
- Change in depressive symptomatology — 3 years
Change in depression symptomatology as assessed by the clinician-rated 17-item Hamilton Depression Rating Scale (range 0-52) - Imaging — 3 years
fMRI target engagement in the subgenual anterior cingulate cortex (sgACC)
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Sunnybrook Health Sciences Centre | Toronto | Ontario | Recruiting |
More Sunnybrook Health Sciences Centre trials in Canada
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT05813093 on ClinicalTrials.gov ↗ ← All trials in Canada